Media Centre
Who to Contact
Callum Spreng
Corporate Communications
DL +44 (0)1896 664103
T +44 (0)1896 664000
E callum.spreng@prostrakan.com
News
Please browse our press releases below. These are all in PDF format. If you do not have an appropriate PDF reader, please download it from the Adobe website here.
Orexo acquires US commercial rights of Abstral and ProStrakan acquires the corresponding rights in the EU and rest of the world
04 June 2012
FDA Approves Shared REMS for all TIRF Pain Treatments
30 December 2011
ProStrakan Receives FDA Approval for Rectiv for the Treatment of Moderate to Severe Pain Associated with Chronic Anal Fissures
22 June 2011
Page 1 of 1
Who to Contact
Callum Spreng
Corporate Communications
DL +44 (0)1896 664103
T +44 (0)1896 664000
E callum.spreng@prostrakan.com